Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors
Vir Biotechnology appointed Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June 9, 2026. Mr. Coughlin brings extensive experience as a former CFO of Neurocrine Biosciences and currently serves on the boards of aTyr Pharma, ADC Therapeutics, and Travere Therapeutics.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.